Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2004 | 01-2004 | 10-2003 | 07-2003 | 04-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,200 | 16,300 | -39,800 | -86,000 | -70,900 |
| Depreciation Amortization | 18,900 | 9,900 | 53,400 | 43,100 | 33,500 |
| Accounts receivable | 1,800 | 11,700 | 1,900 | 33,500 | 2,600 |
| Accounts payable and accrued liabilities | 4,700 | 500 | -29,500 | -37,300 | -30,000 |
| Other Working Capital | 6,800 | -200 | -3,000 | 51,200 | 23,200 |
| Other Operating Activity | -48,700 | -44,400 | 49,000 | 27,600 | 49,900 |
| Operating Cash Flow | $-3,300 | $-6,200 | $32,000 | $32,100 | $8,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -213,300 | -217,800 | N/A | N/A | N/A |
| PPE Investments | -1,000 | 2,700 | -67,600 | -65,500 | -16,100 |
| Net Acquisitions | 3,700 | 5,000 | 1,900 | 500 | 500 |
| Purchase Of Investment | N/A | N/A | -652,200 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 159,500 | 3,700 | 4,000 |
| Other Investing Activity | -2,400 | -200 | 161,400 | 154,500 | 114,800 |
| Investing Cash Flow | $-213,000 | $-210,300 | $-397,000 | $93,200 | $103,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 371,700 | N/A | N/A |
| Debt Repayment | -8,300 | -800 | N/A | 371,500 | -18,400 |
| Common Stock Issued | 4,600 | 1,800 | 8,200 | -31,700 | 2,800 |
| Other Financing Activity | 0 | 0 | -34,500 | 0 | 0 |
| Financing Cash Flow | $-3,700 | $1,000 | $345,400 | $339,800 | $-15,600 |
| Exchange Rate Effect | -100 | -100 | 800 | -300 | -300 |
| Beginning Cash Position | 288,800 | 288,100 | 276,700 | 278,900 | 277,700 |
| End Cash Position | 68,700 | 72,500 | 257,900 | 743,700 | 373,300 |
| Net Cash Flow | $-220,100 | $-215,600 | $-18,800 | $464,800 | $95,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,300 | -6,200 | 32,000 | 32,100 | 8,300 |
| Capital Expenditure | -6,600 | -2,900 | -69,500 | -65,500 | -16,100 |
| Free Cash Flow | -9,900 | -9,100 | -37,500 | -33,400 | -7,800 |